Product Information
GABAPENTIN 250 MG/5 ML SOLN is a generic product labeled by PAI Holdings LLC, priced at $0.0825 per ML under NDC 00121106716. Its NADAC has been published 21 times since Feb 4, 2026.
Strength
250 mg/5mL
Manufacturer
PAI Holdings LLCNDC
00121106716
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA211330On Market Since
6/12/2025
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 250 MG/5 ML SOLN has been published 21 times since Feb 4, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0825 per ML |
|---|---|
| All-time high | $0.0862 (May 13, 2026) |
| All-time low | $0.0825 (Jun 17, 2026) |
| 52-week high | $0.0862 |
| 52-week low | $0.0825 |
| Median price | $0.0852 |
| Average price | $0.0848 |
| Largest weekly change | -2.8% (May 20, 2026) |
| Weeks tracked | 21 |
| Tracking since | Feb 4, 2026 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 250 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 250 MG/5 ML SOLN, manufactured by PAI Holdings LLC, is $0.0825 per ML (NDC 00121106716), effective Jun 24, 2026.
How has the price of GABAPENTIN 250 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 250 MG/5 ML SOLN has held within roughly two percent of its current level. It has been tracked across 21 weekly CMS publications since Feb 4, 2026.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 250 MG/5 ML SOLN?
Since Feb 4, 2026, the NADAC for GABAPENTIN 250 MG/5 ML SOLN has ranged from a low of $0.0825 (Jun 17, 2026) to a high of $0.0862 (May 13, 2026), with a median of $0.0852 per ML.
Are there cheaper alternatives to GABAPENTIN 250 MG/5 ML SOLN?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as GABAPENTIN 250 MG/5 ML SOLN, but none are currently priced below it.
Who manufactures GABAPENTIN 250 MG/5 ML SOLN?
GABAPENTIN 250 MG/5 ML SOLN (NDC 00121106716) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification